Ceridian HCM (NYSE:CDAY – Get Rating) had its target price upped by Cowen from $70.00 to $77.00 in a research report issued to clients and investors on Monday, Stock Target Advisor reports. The firm currently has an “outperform” rating on the stock. Cowen’s price objective would suggest a potential upside of 5.94% from the company’s current price.
A number of other research analysts also recently weighed in on the company. Cowen lifted their price target on Ceridian HCM from $70.00 to $77.00 and gave the company an “outperform” rating in a report on Monday. Deutsche Bank Aktiengesellschaft reduced their target price on Ceridian HCM from $85.00 to $80.00 in a research report on Thursday, August 4th. Credit Suisse Group boosted their target price on shares of Ceridian HCM from $70.00 to $75.00 and gave the company an “outperform” rating in a research note on Thursday, August 4th. BMO Capital Markets lifted their price target on Ceridian HCM from $70.00 to $73.00 and gave the company an “outperform” rating in a report on Thursday, August 4th. Finally, JPMorgan Chase & Co. dropped their target price on Ceridian HCM from $75.00 to $70.00 and set a “neutral” rating for the company in a research report on Thursday, November 3rd. One investment analyst has rated the stock with a sell rating, four have given a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $71.15.
Ceridian HCM Price Performance
Shares of CDAY stock opened at $72.68 on Monday. The firm has a market cap of $11.02 billion, a P/E ratio of -142.51 and a beta of 1.47. The firm has a fifty day moving average of $59.87 and a two-hundred day moving average of $57.05. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.07 and a quick ratio of 1.07. Ceridian HCM has a 1-year low of $43.23 and a 1-year high of $121.22.
Insider Buying and Selling
Institutional Trading of Ceridian HCM
A number of institutional investors have recently made changes to their positions in CDAY. Fifth Third Bancorp boosted its stake in Ceridian HCM by 2.4% during the third quarter. Fifth Third Bancorp now owns 7,376 shares of the company’s stock worth $412,000 after buying an additional 171 shares during the period. Inspire Investing LLC raised its stake in shares of Ceridian HCM by 0.8% during the second quarter. Inspire Investing LLC now owns 22,474 shares of the company’s stock valued at $1,058,000 after acquiring an additional 174 shares in the last quarter. Fisher Asset Management LLC boosted its holdings in shares of Ceridian HCM by 0.6% in the third quarter. Fisher Asset Management LLC now owns 32,154 shares of the company’s stock valued at $1,797,000 after purchasing an additional 191 shares during the period. State of Michigan Retirement System grew its stake in Ceridian HCM by 0.6% in the first quarter. State of Michigan Retirement System now owns 34,510 shares of the company’s stock worth $2,359,000 after purchasing an additional 210 shares in the last quarter. Finally, Royal London Asset Management Ltd. lifted its holdings in shares of Ceridian HCM by 0.5% in the 3rd quarter. Royal London Asset Management Ltd. now owns 44,453 shares of the company’s stock worth $2,487,000 after buying an additional 212 shares during the period.
About Ceridian HCM
Ceridian HCM Holding Inc, together with its subsidiaries, operates as a human capital management (HCM) software company in the United States, Canada, and internationally. It offers Dayforce, a cloud HCM platform that provides human resources (HR), payroll, benefits, workforce management, and talent management functionality; and Powerpay, a cloud HR and payroll solution for the small business market.
- Get a free copy of the StockNews.com research report on Ceridian HCM (CDAY)
- Power Integrations Stock Can Power Your Portfolio
- Don’t Chase Walmart Higher, Wait For Extra Low Prices
- Home Depot Results (and Institutions) Are A Catalyst For Lowe’s?
- Three Penny Stocks Making Big Moves In November
- Agilent Remains In Buy Range Ahead Of Next Week’s Q4 Report
Receive News & Ratings for Ceridian HCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceridian HCM and related companies with MarketBeat.com's FREE daily email newsletter.